Greece grabs attention of European pharma

Greece grabs attention of European pharma

European Commission Vice President Margaritis Schinas and Director General of Medicines for Europe Adrian van den Hoven visited Greece last week.

This was in the context of an international conference titled “Goal 2030: Access For All: Generating a healthy medicines strategy for the next decade,” held by Medicines for Europe and the International Generic and Biosimilar Medicines Association.

On Friday they visited the production plant of Greek pharma industry ELPEN at Pikermi and its Research and Innovation Park that is under construction in Spata, eastern Attica, part of a 120 million-euro investment plan of the firm.


Previous Next
Test Caption
Test Description goes like this
Cookies Preferences
Choose Type of Cookies You Accept Using

These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.

These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.

These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.